R R

What Is Nerlynx?

Nerlynx is a prescription cancer medication containing neratinib, an oral tyrosine kinase inhibitor. It is used for extended adjuvant treatment of certain adults with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer after trastuzumab-based therapy. Nerlynx is also approved with capecitabine for certain adults with advanced or metastatic HER2-positive breast cancer who have received at least two previous anti-HER2 treatment regimens for metastatic disease.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Nerlynx?

Nerlynx is a prescription cancer medication containing neratinib, an oral tyrosine kinase inhibitor. It is used for extended adjuvant treatment of certain adults with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer after trastuzumab-based therapy. Nerlynx is also approved with capecitabine for certain adults with advanced or metastatic HER2-positive breast cancer who have received at least two previous anti-HER2 treatment regimens for metastatic disease.

read more about nerlynx ...

Copy this HTML:

Copy HTML Copied!

How Does Nerlynx Work?

Nerlynx blocks several members of the human epidermal growth factor receptor family, including HER2, HER4, and epidermal growth factor receptor (EGFR). These proteins participate in signaling pathways that can promote cancer cell growth and survival. By inhibiting their tyrosine kinase activity, neratinib interferes with signaling that supports the growth of susceptible tumors. Nerlynx is a targeted treatment rather than a traditional cytotoxic chemotherapy drug.

Who Can Receive Nerlynx Treatment?

Nerlynx is prescribed for specific HER2-positive breast cancer settings. In early-stage disease, it is used as extended adjuvant therapy after trastuzumab-based treatment. In advanced or metastatic disease, it is used with capecitabine after at least two prior anti-HER2 regimens in the metastatic setting. Eligibility depends on tumor characteristics, previous treatment, liver function, and overall health. An oncology specialist determines whether Nerlynx is appropriate.

How Is Nerlynx Taken?

The standard recommended Nerlynx dose is 240 mg orally once daily with food, although dose escalation or reductions can be used to manage adverse effects. Extended adjuvant therapy continues for up to one year or until disease recurrence. In advanced disease, Nerlynx is taken with capecitabine according to a 21-day treatment cycle. Diarrhea prevention or dose escalation is planned by the oncology team. Avoid grapefruit products and follow instructions concerning acid-reducing medicines.

What Are the Side Effects and Warnings of Nerlynx?

Diarrhea is a particularly common and potentially severe adverse effect of Nerlynx. It can lead to dehydration, low blood pressure, electrolyte disturbances, and kidney complications. Other side effects include nausea, vomiting, abdominal pain, fatigue, rash, and reduced appetite. Liver injury and fetal harm are also serious concerns. Clinicians monitor liver function and provide diarrhea management instructions throughout treatment. Report persistent diarrhea or signs of dehydration promptly.

Common Questions About Nerlynx

Is Nerlynx a chemotherapy drug?

Nerlynx is a targeted cancer medication classified as a tyrosine kinase inhibitor rather than traditional cytotoxic chemotherapy. It can be prescribed with capecitabine, a chemotherapy medication, in certain metastatic breast cancer settings.

What type of breast cancer does Nerlynx treat?

Nerlynx treats specific HER2-positive breast cancers. Its use depends on disease stage and prior treatment history.

Why does Nerlynx cause diarrhea?

Nerlynx affects signaling pathways in tissues beyond cancer cells, including the gastrointestinal tract. Severe diarrhea can occur, so treatment plans include preventive measures or dose escalation strategies.

How long is Nerlynx treatment?

Extended adjuvant treatment can continue for up to one year. For advanced or metastatic disease, treatment duration depends on disease progression, tolerability, and the oncologist's assessment.

References

DailyMed - NERLYNX (neratinib) tablet. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d1e41dcf-e82a-47c2-a0ad-6c6eef621834. Date Accessed October 16, 2026.

Neratinib. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK548937/. Date Accessed October 16, 2026.

Neratinib. MedlinePlus. https://medlineplus.gov/druginfo/meds/a617034.html. Date Accessed October 16, 2026.

Neratinib. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Neratinib. Date Accessed October 16, 2026.

Neratinib Maleate. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/drugs/neratinibmaleate. Date Accessed October 16, 2026.